Literature DB >> 9422771

Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene.

A Kuroiwa1, Y Yamashita, M Inui, T Yuasa, M Ono, A Nagabukuro, Y Matsuda, T Takai.   

Abstract

We have analyzed the molecules participating in the inhibitory function of gp49B1, a murine type I transmembrane glycoprotein expressed on mast cells and natural killer cells, as well as the chromosomal location of its gene. As assessed by SDS-polyacrylamide gel electrophoresis and immunoblot analysis, tyrosine-phosphorylated, but not nonphosphorylated, synthetic peptides matching each of the two immunoreceptor tyrosine-based inhibitory motif (ITIM)-like sequences found in the cytoplasmic portion of gp49B1 associated with the approximately 65-kDa tyrosine phosphatase SHP-1 and approximately 70-kDa SHP-2 derived from RBL-2H3 cells. In addition, the phosphotyrosyl peptide matching the second ITIM-like sequence also bound the approximately 145-kDa inositol polyphosphate 5-phosphatase SHIP. Thus, it has been strongly suggested that the inhibitory nature of gp49B involves the recruitment of SHP-1, SHP-2, and SHIP for the delivery of inhibitory signal to the cell interior upon phosphorylation of tyrosine residues in their ITIMs. The gp49B gene has been found to be in the juxtaposition of its cognate gene, gp49A. The gene pair was shown to locate in the B4 band of mouse chromosome 10. In this region, no conserved linkage homology to human chromosome 19, where the genes for killer cell inhibitory receptors are found, has been identified.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422771     DOI: 10.1074/jbc.273.2.1070

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Natural killer cells and mast cells from gp49B null mutant mice are functional.

Authors:  S Rojo; C C Stebbins; M E Peterson; D Dombrowicz; N Wagtmann; E O Long
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Molecular cloning of LILRC1 and LILRC2 in the mouse and the rat, two novel immunoglobulin-like receptors encoded by the leukocyte receptor gene complex.

Authors:  Sigurd Erik Hoelsbrekken; Sigbjørn Fossum; Erik Dissen
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

4.  Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4.

Authors:  J D Schatzle; S Sheu; S E Stepp; P A Mathew; M Bennett; V Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

5.  Identification of the mouse killer immunoglobulin-like receptor-like (Kirl) gene family mapping to chromosome X.

Authors:  Alice Y Welch; Masanori Kasahara; Lisa M Spain
Journal:  Immunogenetics       Date:  2003-02-04       Impact factor: 2.846

6.  Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.

Authors:  Yao Lu; Zhou Jiang; Haijiang Dai; Rujia Miao; Jingxian Shu; Haotian Gu; Xing Liu; Zhijun Huang; Guoping Yang; Alex F Chen; Hong Yuan; Ying Li; Jingjing Cai
Journal:  Hepatology       Date:  2018-02-07       Impact factor: 17.425

Review 7.  Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.

Authors:  Mi Deng; Heyu Chen; Xiaoye Liu; Ryan Huang; Yubo He; Byounggyu Yoo; Jingjing Xie; Samuel John; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Antib Ther       Date:  2021-02-09

8.  LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.

Authors:  Mei-Tzu Su; Sakiko Kumata; Shota Endo; Yoshinori Okada; Toshiyuki Takai
Journal:  Oncoimmunology       Date:  2022-04-05       Impact factor: 8.110

Review 9.  LILRB4, an immune checkpoint on myeloid cells.

Authors:  Ting Yang; Yixin Qian; Xiaoting Liang; Jianbo Wu; Ming Zou; Mi Deng
Journal:  Blood Sci       Date:  2022-05-17

Review 10.  Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.

Authors:  Xunlei Kang; Jaehyup Kim; Mi Deng; Samuel John; Heyu Chen; Guojin Wu; Hiep Phan; Cheng Cheng Zhang
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.